Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2022

View Archived Issues

Novel TIMP3 gene variants tied to early-onset retinopathy

TET2 and KDM6B cooperation tied to chronic myelomonocytic leukemia

AstraZeneca, Mitsubishi Tanabe Pharma present new relaxin receptor 1 agonists

Shanghai Caerulum Pharma Discovery, Azulceu Medicine, Xpiscoric patent abiraterone prodrugs

New coagulation factor XIa inhibitors discovered at Shanghai Leadingtac Pharmaceutical

WDR5/MLL1 interaction inhibitors identified at Etern Biopharma

Hangzhou Purplecrystal Pharma, Hangzhou Innogate Pharma describe GLS1 inhibitors

CXCL8 identified as prognostic biomarker in esophageal squamous cell carcinoma

PARP1 modulates CRC metastasis through Rho GTPase pathway

Balixafortide shows synergy with docetaxel in metastatic prostate cancer preclinical model

DAP3 and DELE1 impact chemosensitization of CRC cells

Lamivudine has beneficial effects in mouse model of Down syndrome

BRCA1 methylation, mutation portend different response to chemotherapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...